Navigation Links
HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
Date:12/19/2007

LEXINGTON, Mass., Dec. 19 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that its three-year contract covering its critical care portfolio with HealthTrust Purchasing Group, LP (HealthTrust), a leading group purchasing organization, has been extended to all Consorta, Inc. members. Consorta, another leading healthcare group purchasing organization, and HealthTrust finalized an agreement that established Consorta as the sixth equity owner of HealthTrust, effective April 18, 2007. The membership of the combined organization is comprised of over 1,300 acute care facilities, including five of the ten largest healthcare systems in the country.

The contract covers IL's portfolio of critical care analyzers, reagents, consumables and service, including IL's flagship products, the new GEM(R) Premier(TM) 4000 and the GEM Premier 3000 analyzers for blood gas, electrolyte and metabolite testing. Additionally, the GEM Premier 4000 includes integrated CO-Oximetry and GEMweb(R) Plus, unique information management software for complete control of all networked analyzers. Both GEM Premier analyzers feature Intelligent Quality Management (iQM(R)), IL's patented, real-time, automated, continuous quality assurance system that helps ensure the quality of every test result while reducing costs and saving time. iQM, coupled with its cartridge-based technology and ease of use, allows the GEM Premier analyzers to be used throughout the hospital, at the point of care and in the lab. The flexibility of the many cartridge sizes and menus makes the GEM Premier analyzers ideally suited to meet the needs of HealthTrust's diverse hospital market.

"Customer satisfaction with our products and services is exceptionally high. HealthTrust and IL enjoy a very positive relationship, which will continue to grow with the addition of the entire Consorta membership," said Brian Durkin, Director of Sales and National Accounts at IL. "We continually strive to help our customers deliver the highest quality patient care and look forward to providing HealthTrust and Consorta members with the best in critical care diagnostics."

Instrumentation Laboratory (http://www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM product offerings, part of the critical care line, include the new GEM Premier 4000 analyzer with Intelligent Quality Management (iQM(R)), GEM Premier 3000 analyzer, GEM OPL(TM), a portable whole blood CO-Oximeter and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP(R), a fully automated, high-productivity analyzer and the ACL ELITE, the latest addition to the ACL family. IL also offers the HemosIL(R) line of reagents. IL is based in Lexington, Massachusetts.

HealthTrust Purchasing Group, LP (HealthTrust), headquartered in Brentwood, Tennessee, is a group purchasing organization that supports not-for-profit and for-profit acute care hospitals, ambulatory surgery centers, alternate care sites, and physician practices. With an annual purchasing volume by its members of more than $13 billion, HealthTrust is committed to obtaining the best price for clinically-recommended products, ensuring their timely delivery and continuously evaluating and improving services to the patients, physicians and clinicians they serve. For more information, please visit http://www.healthtrustpg.com.


'/>"/>
SOURCE Instrumentation Laboratory
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. ATS Medical Expands Open Pivot Heart Valve Offerings
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. BioLife Solutions Expands Scientific Advisory Board
4. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
5. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
6. Pharsight Expands Strategic Consulting Services Team
7. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
8. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
9. AQUISS Expands Into Significant New Territory
10. NanoBio Expands Drug Development Team for Its Anti-Infective Products
11. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... McLean, VA (PRWEB) , ... December 07, 2016 ... ... peer-reviewed medical journal has concluded that “in the setting of previously treated, advanced ... Further refinement in defining the optimal patient population and timing of blood sampling ...
(Date:12/7/2016)... 2016 Neogen Corporation (NASDAQ: NEOG ... Kephart as its chief science officer — a ... responsibilities at Neogen effective Jan. 1. Kephart ... agribusiness unit of Thermo Fisher Scientific, as well as ... His extensive industry experience also includes the management of ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or ... will be presented at the Company,s Annual and Special Meeting. ... Shareholders will take place on Thursday, December 15, 2016 at ... Hall (Room EC1040), 4825 Mount Royal Gate SW, ... A notice of meeting and management information circular, containing the ...
(Date:12/7/2016)... Dec. 7, 2016  Biocom, the association for the ... below following passage of 21 st Century Cures legislation ... 30 by a 392-26 vote and in the Senate on ... attributed to Joe Panetta , president & CEO of ... give hope to millions of patients around the world. The ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016 BioDirection, a privately held medical device ... objective detection of concussion and other traumatic brain injury ... a meeting with the U.S. Food and Drug Administration ... Package. During the meeting company representatives reviewed plans for ... to commencement of a planned pilot trial. ...
(Date:11/22/2016)... , November 22, 2016 According to the new ... Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function ... by MarketsandMarkets, the market is expected to grow from USD 10.74 Billion ... of 16.79% between 2016 and 2022. Continue ... ...
(Date:11/17/2016)...  AIC announces that it has just released a new white paper authored by ... plus high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can ...
Breaking Biology News(10 mins):